Know Cancer

or
forgot password

    • cancer clinical trials in kansas city, KS

    • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Providence Medical Center
    Kansas City, Kansas 66112
    Prostate Cancer
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Veterans Affairs Medical Center - Kansas City
    Kansas City, Kansas 64128
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Providence Medical Center
    Kansas City, Kansas 66112
    Breast Cancer
    Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Head and Neck Cancer
    S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
    Bethany Medical Center

    Trial Locations
    Bethany Medical Center
    Heartland Cancer Research and Treatment Center
    Kidney Cancer
    Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
    Bethany Medical Center

    Trial Locations
    Bethany Medical Center
    Heartland Cancer Research and Treatment Center
    Prostate Cancer
    Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Bethany Medical Center

    Trial Locations
    Bethany Medical Center
    Heartland Cancer Research Network
    Lung Cancer
    Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Brain and Central Nervous System Tumors
    Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia
    4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
    Veterans Affairs Medical Center - Kansas City
    Kansas City, Kansas 64128
    Bladder Cancer
    LY353381 in Preventing Breast Cancer in Women With Hyperplasia
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Colorectal Cancer
    Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Myelodysplastic Syndromes
    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Prostate Cancer
    Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Providence Medical Center
    Kansas City, Kansas 66112
    Adult Acute Lymphoblastic Leukemia in Remission
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Alzheimer Disease
    S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Multiple Myeloma
    Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Glioblastoma Multiforme, Glioblastoma, GBM, Grade IV Astrocytoma, Glioma, Brain Cancer, Brain Tumor
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Endometrial Cancer
    S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Multiple Myeloma, Plasma Cell Myeloma
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Providence Medical Center
    Kansas City, Kansas 66112
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Providence Medical Center
    Kansas City, Kansas 66112
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    University of Kansas Hospital
    Kansas City, Kansas 66160
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Providence Medical Center
    Kansas City, Kansas 66112
    Lymphoma
    Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
    University of Kansas Cancer Center
    Kansas City, Kansas 66160
    Non Small Cell Lung Cancer, Lung Cancer, Stage IIIA Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    University of Kansas Medical Center

    Trial Locations
    University of Kansas Medical Center
    Providence Medical Center
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    University of Kansas Medical Center (Adult Site)
    Kansas City, Kansas 66160
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
    University of Kansas Cancer Center
    Kansas City, Kansas 66160
    Cancer of the Pharynx, Cancer of the Larynx, Cancer of the Nasal Cavity, Paranasal Sinus Neoplasms, Cancer of the Oral Cavity
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Myeloid Leukemia, Chronic, Chronic-Phase
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Ovarian Cancer
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Bladder Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    University of Kansas Medical Center

    Trial Locations
    University of Kansas Medical Center
    Providence Medical Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Kansas City, Kansas 66160
    Neoplasms, Breast
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Head and Neck Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Prostate Cancer
    Protocol for Women at Increased Risk of Developing Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
    GSK Investigational Site
    Kansas City, Kansas 66160
    Prophylaxis for HPV Infections and Associated Cervical Neoplasia
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    University of Kansas Medical Center

    Trial Locations
    University of Kansas Medical Center
    Providence Medical Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Providence Medical Center

    Trial Locations
    Providence Medical Center
    Kansas City Cancer Center-West
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer